Company
Technology
Career
News & Media
Contact
Company
Technology
Career
News & Media
Contact
Day
Oktober 5, 2022
2022-10-05
By
Caroline Weisenbacher
In
PRESS RELEASES
HeartBeat.bio collaborates with Boehringer Ingelheim to investigate cardiac organoids for the development of new treatments for people with heart diseases
VIENNA, Austria – 5 October 2022 – HeartBeat.bio AG has entered a collaboration with Boehringer Ingelheim for the investigation of human cardiac organoids (Cardioids) for high-throughput early safety assessment and drug discovery.
Continue Reading
Neueste Beiträge
First multi-chamber heart organoids unravel humanheart development and disease
HeartBeat.bio raises € 4.5 million in Pre-Series A financing to drive development of organoid screening platform for cardiac drug discovery
HeartBeat.bio collaborates with Boehringer Ingelheim to investigate cardiac organoids for the development of new treatments for people with heart diseases
HeartBeat.bio and Molecular Devices announce collaboration to automate and scale cardiac organoids for high-throughput screening in drug discovery
test
Neueste Kommentare
Neueste Kommentare